Status:
ACTIVE_NOT_RECRUITING
Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Diabetes Melletus
Gastrointestinal Cancers
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In study phase 1, the investigators will prospectively examine the factors related to post-operative glycemic variability and its effect on outcomes in people with both DM and GI cancer after surgery....
Detailed Description
Diabetes mellitus (DM) often coexists with gastrointestinal (GI) cancer, and poor post-operative glycemic control is hypothesized as a major cause of patients' worse health-related outcomes. No study ...
Eligibility Criteria
Inclusion
- Individuals who are planning to undergo GI cancer surgery according to their physician's advice
- Diagnosed with diabetes mellitus
- Aged 18 or above
- Can communicate in Mandarin or Taiwanese
- Agree to participate and sign the informed consent form
Exclusion
- People who are under active treatment for cancer other than GI cancer
- Have a cognitive impairment
- Do not know that they have GI cancer
- Have medical-grade adhesives-related allergy (e.g., redness, swelling, heat, pain, itching, blisters or rash)
- Diagnosed with thrombocytopenia or blood coagulation dysfunction
Key Trial Info
Start Date :
September 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2028
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT07180251
Start Date
September 8 2025
End Date
July 31 2028
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan